Back
ZyVersa Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
ZVSA
ZyVersa Therapeutics
Last Price:
1.12
Seasonality Move:
-77.19%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.ZyVersa Therapeutics Stock Forecast
-
Is ZyVersa Therapeutics Stock Undervalued?
The current ZyVersa Therapeutics [ZVSA] share price is $1.14. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal. - ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will ZyVersa Therapeutics Stock Go Up Next Year?
Data Unavailable
ZyVersa Therapeutics Stock Rating
Data Unavailable
ZyVersa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zyversa.com
52-Week Data
52-Week High:
42.39
52-Week Low:
1.04
Prediction Charts
Market Cap:
2.67M
Price in USD:
1.14
Volume:
242.77K
Beta:
0.66
Technical Analysis
SMA50:
2.00
SMA100:
2.71
SMA200:
4.46
52-Wk Change:
-95.74%
Stock Predictions
-
Is ZyVersa Therapeutics stock public?
Yes, ZyVersa Therapeutics is a publicly traded company. -
What is the ZyVersa Therapeutics stock quote today?
The ZyVersa Therapeutics stock price is 1.14 USD today. -
How to buy ZyVersa Therapeutics stock online?
You can buy ZyVersa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 1.90 | 1.82 | 1.93 | 1.82 |
| Nov-5 | 2.66 | 2.54 | 3.37 | 2.35 |
| Nov-6 | 1.88 | 1.54 | 1.88 | 1.34 |
| Nov-7 | 1.45 | 1.52 | 1.89 | 1.45 |
| Nov-8 | 1.58 | 1.40 | 1.67 | 1.27 |
| Nov-11 | 1.43 | 1.30 | 1.43 | 1.23 |
| Nov-12 | 1.25 | 1.25 | 1.35 | 1.20 |
| Nov-13 | 1.26 | 1.25 | 1.28 | 1.17 |
| Nov-14 | 1.22 | 1.13 | 1.22 | 1.10 |
| Nov-15 | 1.12 | 1.08 | 1.14 | 1.04 |
| Nov-18 | 1.18 | 1.24 | 1.27 | 1.10 |
| Nov-19 | 1.24 | 1.23 | 1.29 | 1.21 |
| Nov-20 | 1.13 | 1.15 | 1.19 | 1.10 |
| Nov-21 | 1.14 | 1.14 | 1.18 | 1.11 |
ZyVersa Therapeutics Earnings
Data Unavailable
ZyVersa Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.